# to Assess the Accuracy and Reliability of the Ga68-Dolacga Positron Emission Tomography Compared to Computer Tomography Volumetry and Indocyanine Green Retention Test for Measurement of Liver Reserve

> **NCT05007548** · PHASE2 · COMPLETED · sponsor: **National Atomic Research Institute, Taiwan** · enrollment: 30 (actual)

## Conditions studied

- Hepatic Carcinoma

## Interventions

- **DRUG:** Ga68-Dolacga Injection

## Key facts

- **NCT ID:** NCT05007548
- **Lead sponsor:** National Atomic Research Institute, Taiwan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-14
- **Primary completion:** 2023-11-20
- **Final completion:** 2023-11-20
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05007548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05007548, "to Assess the Accuracy and Reliability of the Ga68-Dolacga Positron Emission Tomography Compared to Computer Tomography Volumetry and Indocyanine Green Retention Test for Measurement of Liver Reserve". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05007548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*